EP Patent

EP4516355A2 — Stable cannabinoid formulations

Assigned to Fresh Cut Development LLC · Expires 2025-03-05 · 1y expired

What this patent protects

The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

USPTO Abstract

The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Drugs covered by this patent

Patent Metadata

Patent number
EP4516355A2
Jurisdiction
EP
Classification
—
Expires
2025-03-05
Drug substance claim
No
Drug product claim
No
Assignee
Fresh Cut Development LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.